Yes well anything could happen...
"Short" term is EoY and get those HER-Vax Phase 2 results.... if they are as good as has been hinted this will be the pivot point.
Potentially IMU will blow Keytruda out of the market.
Now bearing in mind what happened to Organon the developers of Keytruda....
2007 Schering-Plough bought Organon For $14 Billion then in 2009 Merck bought Schering-Plough for $41.1 Billion
Imagine if IMU were able to get to market with licencing deals..... OMG!!!!!
Then there's an awful lot of potential cream over the next couple of years....
Most exciting investment I've made in my life.
Ann: Imugene completes $90 M placement and launches $5 M SPP, page-324
-
- There are more pages in this discussion • 154 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $757.1K | 13.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2203877 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 244428 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |